Updated: February 26, 2026
How to Save Money on Elahere in 2026: Coupons, Discounts, and Patient Assistance
Author
Peter Daggett

Summarize with AI
- What Does Elahere Actually Cost?
- Option 1: ELAHERE Support Services Co-Pay Assistance
- Option 2: ELAHERE Patient Assistance Program (PAP)
- Option 3: Independent Co-Pay Assistance Foundations
- Option 4: Appeal an Insurance Denial
- Are There GoodRx or Coupon Discounts for Elahere?
- Summary of Financial Assistance Options
Elahere costs ~$29,307 per treatment cycle. Learn about co-pay cards, patient assistance programs, and other ways to reduce the out-of-pocket cost of Elahere in 2026.
Elahere (mirvetuximab soravtansine-gynx) is one of the most expensive cancer treatments available, estimated at approximately $29,307 per treatment cycle. For patients with platinum-resistant ovarian cancer, the cost can feel as overwhelming as the diagnosis itself. The good news: there are meaningful financial assistance programs available, and most commercially insured patients can significantly reduce their out-of-pocket costs.
What Does Elahere Actually Cost?
Elahere is a specialty biologic with no generic equivalent. According to published Canadian Drug Agency assessments, treatment costs approximately $29,307 per patient per 28-day equivalent cycle. Because it's billed through the medical benefit (not pharmacy), costs depend on your insurance plan's infusion/medical cost-sharing structure — not a standard pharmacy co-pay.
A single Elahere vial (100 mg/20 mL) starts at approximately $6,715 from specialty pharmacies. Since most patients need multiple vials per dose (based on adjusted body weight), actual per-infusion costs are significantly higher.
Option 1: ELAHERE Support Services Co-Pay Assistance
AbbVie's ELAHERE Support Services (ESS) offers a co-pay assistance program for eligible commercially insured patients. Key points:
Eligible patients may pay as little as $0 per treatment cycle.
Must have commercial (private) insurance that covers Elahere.
Not available to patients on Medicare (including Part D, Medicare Advantage), Medicaid, TRICARE, or other federal/state programs.
Monthly maximums and other restrictions may apply — review the terms carefully.
To enroll: call 1-833-ELAHERE (1-833-352-4373) or ask your oncologist to submit the ESS enrollment form.
Option 2: ELAHERE Patient Assistance Program (PAP)
For patients who are uninsured or whose insurance does not cover Elahere, AbbVie's Patient Assistance Program (PAP) provides Elahere at no charge to qualifying patients.
Eligibility: U.S. residents (or Puerto Rico) who are uninsured or underinsured and meet financial eligibility criteria.
Apply through ELAHERE Support Services or via myAbbVie Assist at 1-800-222-6885.
Note: Medicare patients under 150% Federal Poverty Level must first provide proof of denial from the Medicare Extra Help / Low Income Subsidy (LIS) program before being evaluated for PAP eligibility.
Option 3: Independent Co-Pay Assistance Foundations
Patients who are on Medicare, Medicaid, or otherwise ineligible for AbbVie's co-pay card may qualify for assistance from independent non-profit foundations. These foundations provide grants to help cover out-of-pocket costs including co-pays, deductibles, and premiums. Major foundations that may have ovarian cancer or specialty oncology funds include:
Patient Advocate Foundation (PAF) Co-Pay Relief Program
HealthWell Foundation — Ovarian Cancer Fund
CancerCare Co-Payment Assistance Program
National Organization for Rare Disorders (NORD) patient assistance programs
Funds in these programs are limited and often open and close throughout the year — apply early.
Option 4: Appeal an Insurance Denial
If your insurance denies Elahere coverage, you have the right to appeal. Insurance denials for Elahere are often based on incomplete documentation. A successful appeal should include:
FRα-positive test results (VENTANA FOLR1 assay report)
Your oncologist's letter of medical necessity citing Elahere's FDA full approval and MIRASOL survival data
Documentation of prior failed therapies (platinum-resistant disease)
Your ESS Case Manager can assist with the appeal process.
Are There GoodRx or Coupon Discounts for Elahere?
Standard prescription drug discount programs like GoodRx, RxSaver, or SingleCare do not apply to Elahere. Because Elahere is billed through the medical benefit (not the pharmacy benefit), those platforms cannot process claims for it. Your best resources for cost reduction are AbbVie's own programs and independent non-profit foundations.
Summary of Financial Assistance Options
Commercial insurance: ESS co-pay card (potentially $0 per cycle) — call 1-833-352-4373
Uninsured/underinsured: AbbVie myAbbVie Assist / ESS PAP — free drug for qualifying patients
Medicare / Medicaid: Independent foundations (Patient Advocate Foundation, HealthWell Foundation, CancerCare)
If you're still struggling to access Elahere — whether due to cost or availability — medfinder can help you locate infusion centers near you that administer Elahere so you can begin treatment once coverage is secured.
See also: Why Is Elahere So Hard to Find? [Explained for 2026].
Frequently Asked Questions
Elahere costs approximately $29,307 per patient per treatment cycle (28-day equivalent), based on Canadian Drug Agency assessments. A single 100 mg/20 mL vial starts at around $6,715, and most patients need multiple vials per dose based on adjusted body weight. There is no generic equivalent.
Yes. AbbVie's ELAHERE Support Services offers a co-pay card for eligible commercially insured patients (potentially $0 per cycle) and a Patient Assistance Program (PAP) providing free Elahere to qualifying uninsured or underinsured patients. Call 1-833-ELAHERE (1-833-352-4373) to enroll.
No. GoodRx and similar prescription drug discount programs cannot be used for Elahere because it is billed through the medical benefit, not the pharmacy benefit. For cost assistance, use AbbVie's own programs (ESS co-pay card or PAP) or independent non-profit foundations like the Patient Advocate Foundation or HealthWell Foundation.
Medicare patients are not eligible for AbbVie's co-pay assistance card. However, they may qualify for the Patient Assistance Program (PAP) if they meet income criteria and can show denial from Medicare Extra Help / Low Income Subsidy. Independent non-profit foundations such as the Patient Advocate Foundation and HealthWell Foundation may also offer co-pay grants for ovarian cancer patients on Medicare.
You have the right to appeal. A strong appeal includes your FRα-positive test results, your oncologist's letter of medical necessity citing the MIRASOL trial survival data (OS HR 0.67, p=0.0046), and documentation of platinum-resistant disease and prior lines of therapy. Your ELAHERE Support Services Case Manager can assist with the appeals process.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Elahere also looked for:
More about Elahere
35,948 have already found their meds with Medfinder.
Start your search today.





